Why cancer patients from the US and Europe are travelling to China for treatment
- Chimeric antigen receptor T-cell CAR-T therapy is drawing foreign cancer patients to Shanghai.
- CAR-T costs $550,000–$850,000 in the US, versus about $150,000–$230,000 in China.
- China approved the world’s first CAR-T treatment for a solid tumour in June 2026.
- One Shanghai hospital says it has treated about 30 overseas patients from 12 countries since 2023.
Source: theprint.in
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
